ASPG and acute lymphoblastic leukemia: Since ATF5 has been shown to regulate asparagine synthetase expression, and asparaginase is a common treatment in childhood ALL, it is possible that interfering with ATF5 pathways in combination with asparaginase treatment could yield better patient outcomes.